RSS   Newsletter   Contact   Advertise with us
Post Online Media

Flexion Therapeutics appoints Mark Stejbach to board

Flexion TherapeuticsFlexion Therapeutics, Inc., a specialty pharmaceutical company, appoints Mark Stejbach to its board of directors.
Mr. Stejbach has more than 25 years of leadership experience in biotech and commercial marketing, sales, managed care, and finance.

Prior to that he served as Senior Vice President and Chief Commercial Officer at Alkermes plc.

Previously, he served at Tengion, Inc. from 2008 to 2012, most recently as Chief Commercial Officer. He previously held senior positions at Merck & Co. and Biogen Idec.

Mr. Stejbach received his MBA from the University of Pennsylvania and a Bachelor of Science in mathematics from Virginia Tech.

 

 LATEST MOVES FROM Massachusetts 


 
 

POST Online Media does not use cookies to collect information about visitors.   OK, hide this message   Third party ads may be using cookies, you can see how here.